Yannis Morel

6.0k total citations · 1 hit paper
52 papers, 2.6k citations indexed

About

Yannis Morel is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yannis Morel has authored 52 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 15 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Yannis Morel's work include Immune Cell Function and Interaction (22 papers), Immunotherapy and Immune Responses (11 papers) and Immune Response and Inflammation (9 papers). Yannis Morel is often cited by papers focused on Immune Cell Function and Interaction (22 papers), Immunotherapy and Immune Responses (11 papers) and Immune Response and Inflammation (9 papers). Yannis Morel collaborates with scholars based in France, United States and Switzerland. Yannis Morel's co-authors include Éric Vivier, Olivier Demaria, Stéphanie Cornen, Marc Daëron, Ruslan Medzhitov, Carine Paturel, Sandra S. Diebold, Shizuo Akira, Catherine Massacrier and Daniel Olive and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Yannis Morel

50 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Harnessing innate immunity in cancer therapy

2019 702 citations Olivier Demaria, Stéphanie Cornen et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yannis Morel France	19	2.0k	764	649	197	188	52	2.6k
Émilie Narni-Mancinelli France	25	2.7k 1.4×	986 1.3×	597 0.9×	227 1.2×	171 0.9×	32	3.4k
Alexandre Iannello Canada	22	2.2k 1.1×	1.3k 1.7×	580 0.9×	286 1.5×	183 1.0×	33	3.0k
Susana Inogés Spain	28	1.8k 0.9×	1.2k 1.6×	912 1.4×	151 0.8×	163 0.9×	65	3.0k
Naohiro Seo Japan	28	1.4k 0.7×	612 0.8×	713 1.1×	134 0.7×	287 1.5×	77	2.4k
Zacarias Garcia France	29	2.0k 1.0×	835 1.1×	649 1.0×	289 1.5×	67 0.4×	42	2.7k
Fabrice Lemaı̂tre France	32	2.5k 1.3×	1.1k 1.5×	717 1.1×	221 1.1×	72 0.4×	50	3.4k
Reem Al‐Daccak France	29	1.2k 0.6×	536 0.7×	829 1.3×	201 1.0×	151 0.8×	76	2.8k
Lianjun Shen China	17	1.6k 0.8×	750 1.0×	1.4k 2.2×	264 1.3×	127 0.7×	49	2.8k
Kristen J. Radford Australia	29	2.2k 1.1×	800 1.0×	837 1.3×	250 1.3×	82 0.4×	67	2.9k
Ian A. Parish Australia	24	3.0k 1.5×	1.0k 1.4×	1.0k 1.5×	290 1.5×	194 1.0×	37	3.9k

Countries citing papers authored by Yannis Morel

Since Specialization

Citations

This map shows the geographic impact of Yannis Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannis Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannis Morel more than expected).

Fields of papers citing papers by Yannis Morel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yannis Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannis Morel. The network helps show where Yannis Morel may publish in the future.

Co-authorship network of co-authors of Yannis Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Yannis Morel. A scholar is included among the top collaborators of Yannis Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yannis Morel. Yannis Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gauthier, Laurent, Angéla Virone-Oddos, Jochen Beninga, et al.. (2023). Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123. Nature Biotechnology. 41(9). 1296–1306. 62 indexed citations

Gauthier, Laurent, Angéla Virone-Oddos, Jochen Beninga, et al.. (2021). 852 Trifunctional NKp46/CD16a-NK cell engager targeting CD123 overcomes acute myeloid leukemia resistance to ADCC. SHILAP Revista de lepidopterología. A893–A893. 2 indexed citations

Demaria, Olivier, Julien Carvelli, Luciana Batista, et al.. (2020). Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19. Cellular and Molecular Immunology. 17(9). 995–997. 57 indexed citations

Demaria, Olivier, Stéphanie Cornen, Marc Daëron, et al.. (2019). Harnessing innate immunity in cancer therapy. Nature. 574(7776). 45–56. 702 indexed citations breakdown →

Bléry, Mathieu, Cécile Bonnafous, Valentine Péri, et al.. (2014). Abstract 5037: Targeting MICA with therapeutic antibodies for the treatment of cancer. Cancer Research. 74(19_Supplement). 5037–5037. 1 indexed citations

Bueren, Jeroen J. Lammerts van, Berris van Kessel, Pascale André, et al.. (2014). Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide. Haematologica. 100(2). 263–268. 89 indexed citations

Oumata, Nassima, Vincent Béringue, Nathalie Desban, et al.. (2013). The Toll-Like Receptor Agonist Imiquimod Is Active against Prions. PLoS ONE. 8(8). e72112–e72112. 24 indexed citations

Salaun, Bruno, Laurence Zitvogel, Carine Asselin‐Paturel, et al.. (2011). TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer. Cancer Research. 71(5). 1607–1614. 93 indexed citations

Conforti, Rosa, Yuting Ma, Yannis Morel, et al.. (2010). Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands. Cancer Research. 70(2). 490–500. 87 indexed citations

10.

Locher, Clara, Rosa Conforti, Laetitia Aymeric, et al.. (2010). Desirable cell death during anticancer chemotherapy. Annals of the New York Academy of Sciences. 1209(1). 99–108. 62 indexed citations

11.

Rajagopal, Deepa, Carine Paturel, Yannis Morel, et al.. (2010). Plasmacytoid dendritic cell–derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists. Blood. 115(10). 1949–1957. 96 indexed citations

12.

Bachelot, Anne, Zeina Chakhtoura, F Kuttenn, Yannis Morel, & P. Touraine. (2006). 17beta-hydroxysteroid dehydrogenase deficiency caused by homozygous h271r mutation. 11. 3 indexed citations

13.

Diebold, Sandra S., Catherine Massacrier, Shizuo Akira, et al.. (2006). Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides. European Journal of Immunology. 36(12). 3256–3267. 219 indexed citations

14.

Fromont, Gaëlle, Bernard Escudier, Yannis Morel, et al.. (2005). Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma. The Journal of Immunology. 174(3). 1338–1347. 164 indexed citations

15.

Castellano, Rémy, Carine Van Lint, Valentine Péri, et al.. (2002). Mechanisms Regulating Expression of the Tumor Necrosis Factor-related light Gene. Journal of Biological Chemistry. 277(45). 42841–42851. 19 indexed citations

16.

Morel, Yannis, Alemseged Truneh, Raymond W. Sweet, Daniel Olive, & Régis Costello. (2001). The TNF Superfamily Members LIGHT and CD154 (CD40 Ligand) Costimulate Induction of Dendritic Cell Maturation and Elicit Specific CTL Activity. The Journal of Immunology. 167(5). 2479–2486. 143 indexed citations

17.

Morel, Yannis, Jean‐Marc Schiano de Colella, Keith C. Deen, et al.. (2000). Reciprocal Expression of the TNF Family Receptor Herpes Virus Entry Mediator and Its Ligand LIGHT on Activated T Cells: LIGHT Down-Regulates Its Own Receptor. The Journal of Immunology. 165(8). 4397–4404. 143 indexed citations

18.

Golay, Alain, Patrick Rouget, Anne‐Françoise Allaz, et al.. (1997). Personalities and alimentary behaviors in obese patients. Patient Education and Counseling. 31(2). 103–112. 11 indexed citations

19.

Morel, Yannis, et al.. (1995). Insulin Sensitivity in Obese Hypertensive Dyslipidemic Patients Treated with Enalapril or Atenolol. Journal of Cardiovascular Pharmacology. 26(2). 306–311. 33 indexed citations

20.

Morel, Yannis, et al.. (1988). Inhibition of the MtTF4 tumor growth by dexamethasone. Journal of Steroid Biochemistry. 30(1-6). 369–373. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact